The US healthcare system continues to face considerable financial strain, although there are pockets of opportunity. Industry EBITDA as a percentage of national health expenditures (NHE) fell from 11.2 percent in 2019 to 8.9 percent in 2024. In 2027, the picture is expected to worsen slightly, with industry EBITDA as a percentage of NHE expected to drop to 8.7 percent. Looking ahead to 2028 and 2029, McKinsey anticipates stronger results underpinned by healthcare players’ actions to buttress their financial position. They will likely move tactically to address pricing and costs and strategically to reallocate resources to growing market segments and pursue business portfolio and scale shifts through M&A and divestitures.
Read the full article: McKinsey: What to Expect in US Healthcare in 2026 and Beyond //
Source: https://www.mckinsey.com/industries/healthcare/our-insights/what-to-expect-in-us-healthcare